Skip to Main Content

Paper Details

Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome.
JAMA Oncol
133
2021
-gene, FVT, Hereditary Cancer Syndrome, PGV, PGVs, Participants, Patients, cancer, cancers, germline, high-, multigene panel, pathogenic germline variants, patients, penetrance variants, solid tumor cancer
Author NameAffiliation
Katie L KunzeMayo Clinic Arizona
Michael A GolafsharMayo Clinic Arizona
Edward D Esplin
Edward D Esplin
Robert L Nussbaum
Richard R SharpCenter for Individualized Medicine, Mayo Clinic
Richard R SharpMayo Clinic
Alan H BryceMayo Clinic Arizona
Alexander Keith StewartCenter for Individualized Medicine, Mayo Clinic
Alexander Keith StewartMayo Clinic Arizona
  • 1 - 10

Datasets

Release 1.2